They have a buy recommendaton by Dutton Associates:
Dutton Associates Announces Investment Opinion: Linkwell Strong Speculative Buy In Initiating Coverage By Dutton Associates
ROSEVILLE, Calif.--(BUSINESS WIRE)--
Dutton Associates initiates coverage of Linkwell Corporation (OTCBB:LWLL) with a Strong Speculative Buy rating and a price target of $.38. The 13-page report by Dutton senior analyst Stanley Ng is available at www.jmdutton.com as well as from First Call, Bloomberg Professional, Zacks, Reuters, Knobias, JCF Group and other leading financial portals.
Linkwell is principally engaged in the development, manufacture, sale and distribution of disinfectant healthcare products, primarily to the medical industry in China. The Company has a nationwide marketing and sales presence throughout all 22 provinces, as well as four autonomous regions and five municipalities in China. This provides Linkwell a major competitive edge over the much larger foreign competitors like 3M and Johnson & Johnson, due to their limited product line and inability to attain critical mass in the China disinfectant market. Cooperation agreements with Ecolab signed in mid-February indicate that even the global leader in the healthcare and disinfectant industry wishes to leverage on Linkwell's established marketing channels to grow its business in the huge China disinfectant market. In our view, Linkwell is an attractive vehicle to participate in China's large and growing disinfectant market, which is driven by increasing health consciousness in China, ongoing government reforms in hospital sanitation, medical standards and disinfectant regulations and the government's educational program to increase awareness about public health and hygienic standards. One of Linkwell's major products, An'erdian Skin Disinfectant, has been chosen for use in all hospitals supporting the 2008 Beijing Olympic Games. Also, Linkwell has been selected to train and license all disinfectant and pest control professionals in China for the Beijing Olympics.
About Dutton Associates
Dutton Associates is one of the largest independent investment research firms in the U.S. Its 30 senior analysts are primarily CFAs, and have expertise in many industries. Dutton Associates provides continuing analyst coverage of over 140 enrolled companies, and its research, estimates, and ratings are carried in all the major databases serving institutions and online investors.
The cost of enrollment in our one-year continuing research program is US $35,000 prepaid for 4 Research Reports, typically published quarterly, and requisite Research Notes. The Firm does not accept any equity compensation. We received $20,000 from the Company for 2 Research Reports commencing on 05/09/2008. Our principals and analysts are prohibited from owning or trading in securities of covered companies. The views expressed in this research report accurately reflect the analyst's personal views about the subject securities or issuer. Neither the analyst's compensation nor the compensation received by us is in any way related to the specific ratings or views contained in this research report or note. Please read full disclosures and analyst background at www.jmdutton.com before investing.
Source: Linkwell Corporation
from www.nasdaq.com
AI
Market Data 
Markets 
